Table of Content



1. Research Scope & Methodology
1.1. Study Objectives
1.2. Scope Of Study
1.3. Methodology
1.4. Assumptions & Limitations

2. Executive Summary
2.1. Market Size & Estimates
2.2. Market Overview

3. Market Dynamics
3.1. Key Drivers
3.1.1. Surging Demand For Stem Cells In Regenerative Medicine
3.1.2. Growing R&D Investments In Stem Cell Therapies & Research
3.1.3. Rising Awareness About Umbilical Cord Stem Cells
3.1.4. Reduced Risk Of Tissue Rejection In Transplants
3.2. Key Restraints
3.2.1. Absence Of A Well-Defined Regulatory Framework For Stem Cell Therapy
3.2.2. High Costs Associated With Stem Cell Procedures
3.2.3. Ethical Issues And Social Complexities
3.2.4. Less Responsiveness In Developed Economies

4. Key Analytics
4.1. Impact Of Covid-19 On Stem Cell Market
4.2. Key Market Trends
4.3. Porter’S Five Forces Analysis
4.3.1. Buyers Power
4.3.2. Suppliers Power
4.3.3. Substitution
4.3.4. New Entrants
4.3.5. Industry Rivalry
4.4. Opportunity Matrix
4.5. Vendor Landscape
4.6. Value Chain Analysis
4.7. Key Buying Criteria
4.7.1. Price
4.7.2. Efficacy
4.7.3. Application And Effectiveness
4.7.4. Accuracy
4.8. Regulatory Framework

5. Market By Therapeutic Application
5.1. Orthopedic Treatments
5.2. Injuries & Wounds
5.3. Oncology Disorders
5.4. Cardiovascular Disorders
5.5. Neurological Disorders
5.6. Diabetes
5.7. Other Therapeutic Applications

6. Market By Product
6.1. Adult Stem Cell
6.1.1. Hematopoietic Stem Cell
6.1.2. Neural Stem Cell
6.1.3. Umbilical Cord Stem Cell
6.1.4. Mesenchymal Stem Cell
6.1.5. Dental Stem Cell
6.2. Human Embryonic Stem Cell
6.3. Pluripotent
6.4. Mouse/Rat Neural

7. Market By Technology
7.1. Cell Acquisition
7.1.1. Bone Marrow Harvest
7.1.2. Umbilical Cord
7.1.3. Apheresis
7.2. Cell Production
7.2.1. Therapeutic Cloning
7.2.2. In Vitro Fertilization (Ivf)
7.2.3. Cell Culture
7.2.4. Isolation
7.3. Cryopreservation
7.4. Expansion & Sub-Culture

8. Market By Application
8.1. Regenerative Medicine
8.2. Drug Discovery And Development

9. Market By Treatment Type
9.1. Allogeneic Stem Cell Therapy
9.2. Autologic Stem Cell Therapy
9.3. Syngeneic Stem Cell Therapy

10. Geographical Analysis
10.1. Asia-Pacific
10.1.1. Market Estimates & Sizes
10.1.2. Key Growth Enablers
10.1.3. Key Challenges
10.1.4. Key Players
10.1.5. Country Analysis
10.1.5.1. China
10.1.5.2. Japan
10.1.5.3. India
10.1.5.4. Australia & New Zealand
10.1.5.5. South Korea
10.1.5.6. Thailand
10.1.5.7. Indonesia
10.1.5.8. Vietnam
10.1.5.9. Rest Of Asia-Pacific

11. Competitive Landscape
11.1. Key Strategic Developments
11.1.1. Acquisitions
11.1.2. Partnerships
11.2. Company Profiles
11.2.1. Allcells Llc
11.2.2. Becton, Dickinson And Company (Bd)
11.2.3. Corning Inc
11.2.4. Lorem Cytori Inc
11.2.5. Ge Healthcare
11.2.6. International Stem Cell Corporation
11.2.7. Merck Kgaa (Sigma Aldrich)
11.2.8. Miltenyi Biotec
11.2.9. Pluri Inc
11.2.10. Qiagen
11.2.11. Smith+Nephew Plc
11.2.12. Stemcell Technologies Inc
11.2.13. Stryker Corporation
11.2.14. Takara Holdings Inc
11.2.15. Thermo Fisher Scientific Inc



List of Figures

List Of Figures
Figure 1: Key Market Trends
Figure 2: Stem Cell Screening Strategies And Their Potential Application
Figure 3: Porter’S Five Forces Analysis
Figure 4: Opportunity Matrix
Figure 5: Vendor Landscape
Figure 6: Value Chain Analysis
Figure 7: Key Buying Criteria
Figure 8: Asia-Pacific Stem Cell Market, Growth Potential, By Therapeutic Application, In 2021
Figure 9: Asia-Pacific Stem Cell Market, By Orthopedic Treatments, 2022-2030 (In $ Million)
Figure 10: Asia-Pacific Stem Cell Market, By Injuries & Wounds, 2022-2030 (In $ Million)
Figure 11: Asia-Pacific Stem Cell Market, By Oncology Disorders, 2022-2030 (In $ Million)
Figure 12: Asia-Pacific Stem Cell Market, By Cardiovascular Disorders, 2022-2030 (In $ Million)
Figure 13: Asia-Pacific Stem Cell Market, By Neurological Disorders, 2022-2030 (In $ Million)
Figure 14: Asia-Pacific Stem Cell Market, By Diabetes, 2022-2030 (In $ Million)
Figure 15: Asia-Pacific Stem Cell Market, By Other Therapeutic Applications, 2022-2030 (In $ Million)
Figure 16: Asia-Pacific Stem Cell Market, Growth Potential, By Product, In 2021
Figure 17: Asia-Pacific Stem Cell Market, By Adult Stem Cell Market, 2022-2030 (In $ Million)
Figure 18: Asia-Pacific Stem Cell Market, Growth Potential, By Adult Stem Cell, In 2021
Figure 19: Asia-Pacific Stem Cell Market, By Hematopoietic Stem Cell Market, 2022-2030 (In $ Million)
Figure 20: Asia-Pacific Stem Cell Market, By Neural Stem Cell Market, 2022-2030 (In $ Million)
Figure 21: Asia-Pacific Stem Cell Market, By Umbilical Cord Stem Cell Market, 2022-2030 (In $ Million)
Figure 22: Asia-Pacific Stem Cell Market, By Mesenchymal Stem Cell Market, 2022-2030 (In $ Million)
Figure 23: Asia-Pacific Stem Cell Market, By Dental Stem Cell Market, 2022-2030 (In $ Million)
Figure 24: Asia-Pacific Stem Cell Market, By Human Embryonic Stem Cell, 2022-2030 (In $ Million)
Figure 25: Asia-Pacific Stem Cell Market, By Pluripotent, 2022-2030 (In $ Million)
Figure 26: Asia-Pacific Stem Cell Market, By Mouse/Rat Neural, 2022-2030 (In $ Million)
Figure 27: Asia-Pacific Stem Cell Market, Growth Potential, By Technology, In 2021
Figure 28: Asia-Pacific Stem Cell Market, By Cell Acquisition, 2022-2030 (In $ Million)
Figure 29: Asia-Pacific Stem Cell Market, Growth Potential, By Cell Acquisition, In 2021
Figure 30: Asia-Pacific Stem Cell Market, By Bone Marrow Harvest, 2022-2030 (In $ Million)
Figure 31: Asia-Pacific Stem Cell Market, By Umbilical Cord, 2022-2030 (In $ Million)
Figure 32: Asia-Pacific Stem Cell Market, By Apheresis, 2022-2030 (In $ Million)
Figure 33: Asia-Pacific Stem Cell Market, By Cell Production, 2022-2030 (In $ Million)
Figure 34: Asia-Pacific Stem Cell Market, Growth Potential, By Cell Production, In 2021
Figure 35: Asia-Pacific Stem Cell Market, By Therapeutic Cloning, 2022-2030 (In $ Million)
Figure 36: Asia-Pacific Stem Cell Market, By In Vitro Fertilization (Ivf), 2022-2030 (In $ Million)
Figure 37: Asia-Pacific Stem Cell Market, By Cell Culture, 2022-2030 (In $ Million)
Figure 38: Asia-Pacific Stem Cell Market, By Isolation, 2022-2030 (In $ Million)
Figure 39: Asia-Pacific Stem Cell Market, By Cryopreservation, 2022-2030 (In $ Million)
Figure 40: Asia-Pacific Stem Cell Market, By Expansion & Sub-Culture, 2022-2030 (In $ Million)
Figure 41: Asia-Pacific Stem Cell Market, Growth Potential, By Application, In 2021
Figure 42: Asia-Pacific Stem Cell Market, By Regenerative Medicine, 2022-2030 (In $ Million)
Figure 43: Asia-Pacific Stem Cell Market, By Drug Discovery And Development, 2022-2030 (In $ Million)
Figure 44: Asia-Pacific Stem Cell Market, Growth Potential, By Treatment Type, In 2021
Figure 45: Asia-Pacific Stem Cell Market, By Allogeneic Stem Cell Therapy, 2022-2030 (In $ Million)
Figure 46: Asia-Pacific Stem Cell Market, By Autologic Stem Cell Therapy, 2022-2030 (In $ Million)
Figure 47: Asia-Pacific Stem Cell Market, By Syngeneic Stem Cell Therapy, 2022-2030 (In $ Million)
Figure 48: Asia-Pacific Stem Cell Market, Country Outlook, 2021 & 2030 (In%)
Figure 49: China Stem Cell Market, 2022-2030 (In $ Million)
Figure 50: Japan Stem Cell Market, 2022-2030 (In $ Million)
Figure 51: India Stem Cell Market, 2022-2030 (In $ Million)
Figure 52: Australia & New Zealand Stem Cell Market, 2022-2030 (In $ Million)
Figure 53: South Korea Stem Cell Market, 2022-2030 (In $ Million)
Figure 54: Thailand Stem Cell Market, 2022-2030 (In $ Million)
Figure 55: Indonesia Stem Cell Market, 2022-2030 (In $ Million)
Figure 56: Vietnam Stem Cell Market, 2022-2030 (In $ Million)
Figure 57: Rest Of Asia-Pacific Stem Cell Market, 2022-2030 (In $ Million)

List of Tables

LIST OF TABLES
TABLE 1: ASIA-PACIFIC MARKET SNAPSHOT - STEM CELL
TABLE 2: EXAMPLES OF APPROVED CELL THERAPY PRODUCTS
TABLE 3: REGULATORY FRAMEWORK
TABLE 4: ASIA-PACIFIC STEM CELL MARKET, BY THERAPEUTIC APPLICATION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 5: ASIA-PACIFIC STEM CELL MARKET, BY THERAPEUTIC APPLICATION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 6: ASIA-PACIFIC STEM CELL MARKET, BY PRODUCT, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 7: ASIA-PACIFIC STEM CELL MARKET, BY PRODUCT, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 8: ASIA-PACIFIC STEM CELL MARKET, BY ADULT STEM CELL, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 9: ASIA-PACIFIC STEM CELL MARKET, BY ADULT STEM CELL, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 10: ASIA-PACIFIC STEM CELL MARKET, BY TECHNOLOGY, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 11: ASIA-PACIFIC STEM CELL MARKET, BY TECHNOLOGY, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 12: ASIA-PACIFIC STEM CELL MARKET, BY CELL ACQUISITION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 13: ASIA-PACIFIC STEM CELL MARKET, BY CELL ACQUISITION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 14: ASIA-PACIFIC STEM CELL MARKET, BY CELL PRODUCTION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 15: ASIA-PACIFIC STEM CELL MARKET, BY CELL PRODUCTION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 16: ASIA-PACIFIC STEM CELL MARKET, BY APPLICATION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 17: ASIA-PACIFIC STEM CELL MARKET, BY APPLICATION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 18: ASIA-PACIFIC STEM CELL MARKET, BY TREATMENT TYPE, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 19: ASIA-PACIFIC STEM CELL MARKET, BY TREATMENT TYPE, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 20: ASIA-PACIFIC STEM CELL MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 21: ASIA-PACIFIC STEM CELL MARKET, BY COUNTRY, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 22: LEADING PLAYERS OPERATING IN ASIA-PACIFIC STEM CELL MARKET
TABLE 23: LIST OF ACQUISITIONS
TABLE 24: LIST OF PARTNERSHIPS